Interestingly, we further found DYRK1A expression to be highly upregulated in triple negative breast cancer (TNBC), the most aggressive form of the disease, compared to other breast cancer molecular subtypes (Fig. 1b). This evidence concerns the gene DYRK1A and breast carcinoma.